BusinessOcera Therapeutics Announces Late-Breaker Abstract Accepted for Presentation at the AASLD Liver Meeting 2016By Nasdaq OMXOct 24, 2016, 1:05 PM UTC
BusinessOcera Announces Enrollment Completion From Phase 2a NIH-Sponsored Study of OCR-002 in the Treatment of Patients with Acute Liver FailureBy Nasdaq OMXSep 21, 2016, 8:05 PM UTC
BusinessOcera to Present at the Ladenburg Thalmann 2nd Annual Healthcare ConferenceBy Nasdaq OMXSep 20, 2016, 1:10 PM UTC
BusinessOcera Therapeutics Announces Publication of Promising Preclinical Data in Support of Its Ammonia Scavenger OCR-002 in the Journal of HepatologyBy Nasdaq OMXApr 11, 2016, 1:05 PM UTC
